Parametric Portfolio Associates’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.17M Buy
60,589
+11,856
+24% +$272K ﹤0.01% 2708
2021
Q4
$1.59M Buy
+48,733
New +$1.96M ﹤0.01% 2580

Other funds holding GDRX

Parametric Portfolio Associates's GDRX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its GoodRx Holdings (GDRX) stake by 24% in Q1 2022, buying an estimated $272K and bringing the position to 60,589 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2708.

Parametric Portfolio Associates first reported a position in GDRX in Q4 2021 and has held it in 2 quarters since. The position peaked at $1.59M in Q4 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Parametric Portfolio Associates held 60,589 shares of GoodRx Holdings worth $1.17M as of Q1 2022.
  • Parametric Portfolio Associates bought 11,856 GoodRx Holdings shares in Q1 2022, an estimated $272K.
  • GoodRx Holdings made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2708 holding.
  • Parametric Portfolio Associates first reported a position in GoodRx Holdings in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's GoodRx Holdings position peaked at $1.59M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.